Evidence map›Paper›PMID 42888542›Full record

Observational studyMedicine2026

TyG-ABSI and TyG-WWI as insulin-resistance body shape markers of mortality in middle-aged and older adults within the cardiovascular-kidney-metabolic framework: A multi-cohort observational study with external survival-model validation.

Fangping Xiao, Hui Guo, Lei Wang, Yanyan Qu, Chunsun Dai

Abstract readObservational Study
In one paragraph

Observational study in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fangping XiaoCenter for Kidney Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Hui GuoDepartment of Cardiology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Lei WangDepartment of Pathology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China.
Yanyan QuCenter for Kidney Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Chunsun DaiCenter for Kidney Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.ORCID 0000-0003-2592-0121

Funding

the National Natural Science Foundation of China 81970627the National Natural Science Foundation of China 82370688the National Natural Science Foundation of China 82400988 to LW
6 · The paper itself

Abstract

Insulin resistance, adiposity, kidney dysfunction, and cardiovascular disease are closely interconnected in middle-aged and older adults and are central to the cardiovascular-kidney-metabolic (CKM) framework. Triglyceride-glucose (TyG)-related indices combine routine lipid, glucose, and anthropometric information, but their cross-population consistency and incremental prognostic value for mortality-risk assessment remain uncertain. We analyzed harmonized participant-level data from National Health and Nutrition Examination Survey (NHANES), English Longitudinal Study of Ageing (ELSA), China Health and Retirement Longitudinal Study (CHARLS), and Health and Retirement Study (HRS), with HRS used as a sensitivity cohort. Eligible participants were aged ≥ 50 years, had follow-up beyond baseline, available mortality status, and complete data for 7 TyG-related indices. Cohort-specific Cox models estimated associations of standardized TyG, TyG-body mass index, TyG-waist circumference, TyG-waist-to-height ratio, TyG-weight-adjusted waist index (WWI), TyG-a body shape index (ABSI), and TyG-body roundness index with all-cause mortality. Nonlinearity, proportional-hazards assumptions, sensitivity analyses, NHANES heart disease mortality, incremental prediction, and survival machine learning with external validation were further assessed. The primary analytic sample included 21,044 NHANES participants, 5454 ELSA participants, and 11,157 CHARLS participants, among whom 5566, 116, and 1393 deaths occurred during follow-up, respectively. The HRS sensitivity cohort included 4103 participants and 484 deaths. In fully adjusted Cox models, all 7 TyG-related indices were associated with higher all-cause mortality in NHANES, with the strongest associations observed for TyG-ABSI (hazard ratio [HR] 1.159, 95% confidence interval [CI] 1.115-1.205) and TyG-WWI (HR 1.155, 95% CI 1.113-1.199). In CHARLS, TyG-ABSI was positively associated with mortality (HR 1.088, 95% CI 1.029-1.151), whereas estimates in ELSA were imprecise. In HRS sensitivity analyses, TyG-WWI and TyG-ABSI remained positively associated with mortality. Adding TyG-related indices to a clinical Cox prediction framework produced only minimal absolute gains in discrimination. The final TyG-ABSI extreme gradient boosting survival model yielded 5-year time-dependent area under the curves of 0.808 in the NHANES internal test set and 0.760 in CHARLS. A research-use web calculator was developed for 5-year and 8-year mortality-risk estimation. TyG-ABSI and TyG-WWI were the most consistent TyG-related body shape markers of all-cause mortality across international aging cohorts. Although TyG-ABSI supported externally validated survival prediction, its incremental predictive value beyond established clinical and CKM variables was limited. These findings suggest that TyG-related body shape indices may serve primarily as interpretable, low-cost CKM risk markers rather than standalone prediction tools.

Indexed as

Blood GlucoseCardiovascular DiseasesInsulin ResistanceTriglyceridesAgedBiomarkersBody Mass IndexChinaCohort StudiesFemaleHumansLongitudinal StudiesMaleMiddle AgedNutrition SurveysProportional Hazards ModelsBiomarkersBlood GlucoseTriglyceridescardiovascular-kidney-metabolicmortalitysurvival analysissurvival machine learningtriglyceride-glucose index

Identifiers

PMID42888542
PMCPMC13681115

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.